Brain Networks and Mobility Function: B-NET
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 70 - 85 |
| Updated: | 3/30/2019 |
| Start Date: | July 20, 2018 |
| End Date: | December 31, 2021 |
| Contact: | Stephen Kritchevsky, PhD |
| Email: | skritche@wakehealth.edu |
| Phone: | 336-713-8987 |
Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal
role in mobility function with age-associated CNS changes strongly contributing to declining
mobility. Studies linking the brain to mobility have used anatomical measures like brain
volume and white matter integrity, and suggest that damage to the connecting fibers of the
brain (white matter) is related to mobility impairment. Unfortunately, age-related structural
white matter damage appears irreversible and only indirectly indicates the functional
connectivity between brain regions. It is believed that functional brain network analyses
have the potential to identify individuals that may benefit from interventions prior to the
development of irreversible white matter lesions. The current project will assess both
physical and cognitive function and integrate these variables with measures of brain network
connectivity.
role in mobility function with age-associated CNS changes strongly contributing to declining
mobility. Studies linking the brain to mobility have used anatomical measures like brain
volume and white matter integrity, and suggest that damage to the connecting fibers of the
brain (white matter) is related to mobility impairment. Unfortunately, age-related structural
white matter damage appears irreversible and only indirectly indicates the functional
connectivity between brain regions. It is believed that functional brain network analyses
have the potential to identify individuals that may benefit from interventions prior to the
development of irreversible white matter lesions. The current project will assess both
physical and cognitive function and integrate these variables with measures of brain network
connectivity.
Studies linking the brain to mobility have used anatomical measures like brain volume and
white matter integrity, and suggest that damage to the connecting fibers of the brain (white
matter) is related to mobility impairment. Unfortunately, age-related structural white matter
damage appears irreversible and only indirectly indicates the functional connectivity between
brain regions. The preliminary data show that directly assessed patterns of functional
connectivity correlate with mobility function and can be changed by interventions that
improve mobility function. It is not known how changes in CNS functional connectivity relate
to changes in mobility, information critical for the design of interventions targeting CNS
connectivity to improve mobility impairments. It is clear that structural connectivity
underlies functional connectivity, and that structural brain lesions result in altered
functional connections. B-NET will assess white matter (WM) disease burden and
microstructural changes and relate these changes to functional brain network connectivity. We
hypothesize that because sensory motor cortex community structure (SMC-CS) characterizes
current brain organization, it will be associated with mobility function independently of
anatomical damage markers. Such knowledge may permit earlier identification of persons at
high risk for mobility decline and facilitate earlier and better targeted interventions.
white matter integrity, and suggest that damage to the connecting fibers of the brain (white
matter) is related to mobility impairment. Unfortunately, age-related structural white matter
damage appears irreversible and only indirectly indicates the functional connectivity between
brain regions. The preliminary data show that directly assessed patterns of functional
connectivity correlate with mobility function and can be changed by interventions that
improve mobility function. It is not known how changes in CNS functional connectivity relate
to changes in mobility, information critical for the design of interventions targeting CNS
connectivity to improve mobility impairments. It is clear that structural connectivity
underlies functional connectivity, and that structural brain lesions result in altered
functional connections. B-NET will assess white matter (WM) disease burden and
microstructural changes and relate these changes to functional brain network connectivity. We
hypothesize that because sensory motor cortex community structure (SMC-CS) characterizes
current brain organization, it will be associated with mobility function independently of
anatomical damage markers. Such knowledge may permit earlier identification of persons at
high risk for mobility decline and facilitate earlier and better targeted interventions.
Inclusion Criteria:
- Community-dwelling adults aged ≥70 to ≤85 years
- Willing to provide informed consent; ability to communicate with study personnel.
Exclusion Criteria:
- Serious or uncontrolled chronic disease such as:
- Cancer (stage 3 or 4) or having had radiation or chemotherapy in the past year
- Uncontrolled angina
- Heart failure (stage 3-4)
- Respiratory disease requiring the use of oxygen
- Uncontrolled endocrine/metabolic disease (fasting glucose >250mg/dL)
- Liver failure (AST > 40IU/L and/or ALT > 44 IU/L)
- Renal failure requiring dialysis
- Clinically diagnosed neurologic diseases: Parkinson's disease; Amyotrophic Lateral
Sclerosis (ALS); Multiple Sclerosis, prior stroke with residual effects lasting longer
than 24hrs
- Diagnosis of schizophrenia, bipolar, or other psychotic disorder
- Diagnosis of Alzheimer's disease or evidence of impaired cognitive function
- Prior traumatic brain injury with residual deficits
- Unwilling or unable to have an MRI brain scan (see MRI screening form).
- Dependent on a walker or another person to ambulate.
- Plans to relocate in the next 2- 3 years.
- Single or double amputee
- Musculoskeletal impairments severe enough to preclude functional testing
- Participating in an exercise or cognitive enhancing intervention
- Any other reason the PI or study physician feels the participant would not adhere to
the protocol
We found this trial at
1
site
Click here to add this to my saved trials
